Novocell CEO Moves to Nonprofit Juvenile Diabetes Research Foundation

The New York-based Juvenile Diabetes Research Foundation has named San Diego-based Novocell CEO Alan Lewis as its new chief executive. Lewis plans to step down from Novocell, a stem cell company developing a treatment for Type 1 diabetes, on Jan. 1. Lewis told The San Diego Union-Tribune Novocell is in a good financial shape to continue its move into clinical trials.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call 858-202-0492

Comments | Reprints | Share: